1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E8D20845E8895475002586FD007FDB2E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(FIELD%20Subject%20CONTAINS%20%22launch%22)%20AND%20(%22launch%22)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&SearchFuzzy=1&ItemCatalog=BMR&SearchOrder=1&Start=21&Count=10
18
19OpenForm&Query=(FIELD%20Subject%20CONTAINS%20%22launch%22)%20AND%20(%22launch%22)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&SearchFuzzy=1&ItemCatalog=BMR&SearchOrder=1&Start=21&Count=10
203.236.170.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 21 - 30 of 32 Total Hits, Sorted by Relevance.

    |    

Best Practices in Launch Optimization: How Promotional Efficiency can be Leveraged to Support Multiple Products & IndicationsDirect access to this research is not included with your membership level.

In today’s marketplace, launching multiple products for a common therapeutic area is both resource-intensive and strategically challenging... (ID PSM-293)
Companies Profiled: Bayer Healthcare, Shionogi Inc., Roche Diagnostics, Mylan, more ...

Educating the Market to Support Successful Product Launches in OncologyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

Click Download link on right for complimentary excerpt Aggressive market pressures challenge companies to rapidly deliver new products in the marke... (ID SM-190)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Success Factors and Failure Points in Biopharmaceutical Product Launches: An Updated Road Map for Strong Market EntryDirect access to this research is not included with your membership level.

The last several years have been marked by dozens of pharmaceutical product launches; some products took off at launch while many others fell flat... (ID PSM-261)
Companies Profiled: Abbott Laboratories, Amgen, Actelion, AstraZeneca, more ...

Success Factors and Failure Points in Cardiovascular Product LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the cardiovascular therapeutic area... (ID PSM-264)
Companies Profiled: GlaxoSmithKline, Bristol-Myers Squibb, Roche, Lilly, more ...

Educating KOLs, Physicians, Patients and Payers to Support Successful Product LaunchesDirect access to this research is not included with your membership level.

The bio-pharmaceutical marketplace continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-248)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Shaping the Marketplace to Support Successful Oncology Product Launches: Tactics for Educating KOLs, Physicians, Patients and PayersDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

The bio-pharmaceutical marketplace – and the oncology therapeutic area in particular – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-243)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Shaping the Marketplace to Support Successful Diabetes Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers Direct access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.

The pharmaceutical, biotech and medical device marketplaces are rapidly changing due to new medicines, new technologies, new therapeutic approaches and a challenging regulatory environment... (ID SM-191)
Companies Profiled: GlaxoSmithKline , ARIAD, Pfizer, Integrated Communications Corp., more ...

Success Factors and Failure Points in Metabolic Product LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the metabolic therapeutic area... (ID PSM-266)
Companies Profiled: GlaxoSmithKline, Bristol-Myers Squibb, Roche, Lilly, more ...

Educating the Marketplace to Support Successful Diabetes Product LaunchesDirect access to this research is not included with your membership level.

The bio-pharmaceutical marketplace – including the diabetes therapeutic area – continues to evolve as new medicines and technologies create valuable market opportunities... (ID PSM-246)
Companies Profiled: GlaxoSmithKline, ARIAD, Pfizer, Integrated Communications Corp., more ...

Success Factors and Failure Points in Oncology Product LaunchesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

The biopharmaceutical sector has seen dozens of new product launches in the last few years, including some notable new drugs targeting the oncology therapeutic area... (ID PSM-267)
Companies Profiled: GlaxoSmithKline, Bristol-Myers Squibb, Roche, Lilly, more ...